These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23738491)

  • 41. Publication of OIG Special Fraud Alerts: home health fraud, and fraud and abuse in the provision of medical supplies to nursing facilities--HHS. Notice.
    Fed Regist; 1995 Aug; 60(154):40847-51. PubMed ID: 10144395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medicare program; revisions to the Medicare Advantage and prescription drug benefit programs: clarification of compensation plans. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Nov; 73(221):67406-14. PubMed ID: 19137670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Health Insurance Portability and Accountability Act of 1996 and the evolution of the government's anti-fraud and abuse agenda.
    Acosta T; Young HJ
    J Health Hosp Law; 1997 Mar; 30(1):37-50. PubMed ID: 10167092
    [No Abstract]   [Full Text] [Related]  

  • 44. Patient confidentiality statutes in Medicare & Medicaid fraud investigations.
    Khajezadeh D
    Am J Law Med; 1987; 13(1):105-37. PubMed ID: 3332560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complex rules in place to combat fraud and abuse. Part I: Understanding the basics.
    Brown CA
    Bull Am Coll Surg; 2000 Aug; 85(8):15-8, 32. PubMed ID: 11349553
    [No Abstract]   [Full Text] [Related]  

  • 46. Understanding the current law and the gray areas of fraud and abuse.
    Epstein SB; Valiant C
    Internist; 1990 Jun; 31(6):11-4. PubMed ID: 10112274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Socioeconomic tips of the month. Complying with anti-fraud and abuse requirements.
    Bull Am Coll Surg; 1999 Dec; 84(12):47, 60. PubMed ID: 11349557
    [No Abstract]   [Full Text] [Related]  

  • 48. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are you committing health care fraud under the False Claims Act? The answer may not be as simple as you think.
    Goldberg MK
    J Med Pract Manage; 2002; 17(4):206-9. PubMed ID: 11873449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New federal anti-fraud law turns up the heat.
    Erickson JA
    Contemp Longterm Care; 1997 Jan; 20(1):30. PubMed ID: 10164180
    [No Abstract]   [Full Text] [Related]  

  • 51. Health care reform's impact on health care fraud enforcement.
    Danzig A; Welch SS; Burgar J; Marshall E; Gregory AG
    J Med Assoc Ga; 2009; 98(4):17-9. PubMed ID: 20131699
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

  • 53. Examining the impact of Part D on nursing home residents.
    Hudson N
    Find Brief; 2010 May; 13(4):1-3. PubMed ID: 21121179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fraud and abuse provisions in the Health Insurance Portability and Accountability Act: a guide to the new act for physicians.
    McCampbell RG
    J Okla State Med Assoc; 1997 Apr; 90(4):139-41. PubMed ID: 9143159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinton wants Medicare anti-fraud effort expanded; labs focus on legislative priorities.
    Szabo J
    MLO Med Lab Obs; 2000 Mar; 32(3):14. PubMed ID: 10947449
    [No Abstract]   [Full Text] [Related]  

  • 56. Control of fraud and abuse in Medicare and Medicaid.
    Pies HE
    Am J Law Med; 1977; 3(3):323-32. PubMed ID: 415602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complex rules in place to combat fraud and abuse. Part II: The surgical perspective on selected federal programs.
    Brown CA
    Bull Am Coll Surg; 2000 Oct; 85(10):8-12. PubMed ID: 11351852
    [No Abstract]   [Full Text] [Related]  

  • 58. Some legal and managerial strategies for managing healthcare fraud.
    Paul RJ; Townsend JB
    Health Mark Q; 1997; 14(3):19-33. PubMed ID: 10167310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Congress tightens fraud and abuse laws.
    Miles F; Tisdall NP
    Provider; 1997 Nov; 23(11):101, 104. PubMed ID: 10173664
    [No Abstract]   [Full Text] [Related]  

  • 60. Oversight under fire. Audit criticizes Medicare Advantage watchdog.
    Carlson J
    Mod Healthc; 2013 Jan; 43(2):10. PubMed ID: 23390696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.